Showing results (11-20 of 108) with videos related to
Sort By:
Pageof 11
The Journal of Biological Chemistry|November 2, 2012
The mRNA-stabilizing factor HuR protein is targeted by β-TrCP protein for degradation in response to glycolysis inhibitionPo-Chen Chu, Hsiao-Ching Chuang, Samuel K Kulp, et al.Cancer Letters|September 16, 2008
PPARgamma-independent antitumor effects of thiazolidinedionesShuo Wei, Jian Yang, Su-Lin Lee, et al.Breast Cancer Research and Treatment|June 9, 2012
Differential anti-proliferative activities of poly(ADP-ribose) polymerase (PARP) inhibitors in triple-negative breast cancer cellsHsiao-Ching Chuang, Naval Kapuriya, Samuel K Kulp, et al.American Journal of Veterinary Research|July 3, 2008
Evaluation of the effects of histone deacetylase inhibitors on cells from canine cancer cell linesWilliam C Kisseberth, Sridhar Murahari, Cheryl A London, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2006
Antitumor effects of a novel phenylbutyrate-based histone deacetylase inhibitor, (S)-HDAC-42, in prostate cancerSamuel K Kulp, Chang-Shi Chen, Da-Sheng Wang, et al.Breast Cancer Research and Treatment|February 28, 2002
Involvement of breast epithelial-stromal interactions in the regulation of protein tyrosine phosphatase-gamma (PTPgamma) mRNA expression by estrogenically active agentsSuling Liu, Samuel K Kulp, Yasuro Sugimoto, et al.Oncotarget|March 31, 2015
A novel HIF-1α-integrin-linked kinase regulatory loop that facilitates hypoxia-induced HIF-1α expression and epithelial-mesenchymal transition in cancer cellsChih-Chien Chou, Hsaio-Ching Chuang, Santosh B Salunke, et al.American Journal of Veterinary Research|July 3, 2010
Biological activity of gemcitabine against canine osteosarcoma cell lines in vitroMelanie B McMahon, Misty D Bear, Samuel K Kulp, et al.Carcinogenesis|May 8, 2009
alpha-Tocopheryl succinate and derivatives mediate the transcriptional repression of androgen receptor in prostate cancer cells by targeting the PP2A-JNK-Sp1-signaling axisPo-Hsien Huang, Dasheng Wang, Hsiao-Ching Chuang, et al.Journal of Medicinal Chemistry|March 14, 2008
Pharmacological exploitation of the peroxisome proliferator-activated receptor gamma agonist ciglitazone to develop a novel class of androgen receptor-ablative agentsJian Yang, Shuo Wei, Da-Sheng Wang, et al.Pageof 11